Skip to main content

Table 4 Univariate and multivariate analysis of risk factors associated with hemorrhagic pneumonia in hematological patients with SM bacteremia

From: Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study

Characteristics

Univariate analysis

Multivariate analysis

OR (95% CI)

P-value

OR (95% CI)

P-value

Age

1.030 (0.994–1.068)

0.105

  

Polymicrobial bacteremia

1.917 (0.490–7.494)

0.350

  

Neutropenia

5.176 (1.252–21.411)

0.023

4.988 (1.040–23.920)

0.045

Hemoglobin < 60 g/L

1.261 (0.433–3.668)

0.671

  

Platelet< 50,000/uL

1.500 (0.230–9.763)

0.671

  

Fibrinogen< 2 g/L

2.100 (0.537–8.217)

0.286

  

PT > 13.5 s

2.692 (0.883–8.206)

0.082

  

APTT> 33.5 s

2.265 (0.694–7.389)

0.175

  

D-Dimer>700μg/L FEU

1.568 (0.389–6.319)

0.527

  

Albumin< 30 g/L

1.440 (0.487–4.255)

0.509

  

Globulin< 20 g/L

1.261 (0.433–3.668)

0.671

  

C-reactive protein≥10 mg/dl

1.973 (0.638–6.106)

0.238

  

Procalcitonin > 0.5μg/L

9.375 (1.849–47.522)

0.007

11.322 (1.943–65.956)

0.007

HSCT

1.167 (0.335–4.060)

0.809

  

Inadequate initial antimicrobial treatment

1.451 (0.481–4.377)

0.508

  

Central venous catheter

2.717 (0.479–15.402)

0.259

  

Prior tigecycline therapy within 1 month

4.364 (1.383–13.772)

0.012

4.482 (1.135–17.702)

0.032

Prior carbapenem therapy within 1 month

1.250 (0.297–5.256)

0.761

  
  1. Abbreviations: OR odds rate, CI confidence interval, PT prothrombin time; APTT activated partial thromboplastin time, HSCT hematopoietic stem cell transplantation